New Medical Centre Alexandria results, Q3 2023
Net profit, assets, equity and cash flow for Q3 2023, against the same period a year earlier, from the published financial statements.
Net profit6.31 millionEGP · +1492.0% vs the same period a year earlier
Total assets295 millionEGP · −6.5% vs the same period a year earlier
Shareholders' equity199 millionEGP · −19.0% vs the same period a year earlier
Operating cash flow1.53 millionEGP · +109.0% vs the same period a year earlier
In short
- New Medical Centre Alexandria's net profit for Q3 2023 was about 6.31 million EGP, up +1492.0% from -453 thousand EGP in Q3 2022.
- Total assets at the end of Q3 2023 were about 295 million EGP, and shareholders' equity about 199 million EGP.
- Operating cash flow for Q3 2023 was positive at 1.53 million EGP.
Key lines against the same period a year earlier
This periodQ3 2022Change
Net profit6.31 million-453 thousand+1492.0%
Gross profit24.31 million30.45 million−20.2%
Total assets295 million315 million−6.5%
Total liabilities95.62 million69.35 million+37.9%
Shareholders' equity199 million246 million−19.0%
Total liabilities and equity295 million315 million−6.5%
Operating cash flow1.53 million-17.14 million+109.0%
Investing cash flow-1.31 million-1.72 million+23.7%
Financing cash flow—-1.71 million—
Net change in cash221 thousand-20.56 million+101.1%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
New Medical Centre Alexandria's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy